Table 4.
Determination of ziprasidone in human urine and serum.
| Sample | Amount added | Foundc | Recoveryc ± RSD (%) | % Bias |
|---|---|---|---|---|
| Urine 1 | 2.80a | 2.70 | 96.4 ± 1.2 | −3.57 |
| Urine 2 | 4.70a | 4.73 | 100.6 ± 0.5 | 0.64 |
| Urine 3 | 8.30a | 8.08 | 97.4 ± 2.0 | −2.65 |
| Urine 4 | 12.0a | 12.3 | 102.5 ± 1.4 | 2.50 |
| Serum 1 | 0.90b | 0.93 | 103.3 ± 1.1 | 3.33 |
| Serum 2 | 2.80b | 2.79 | 99.6 ± 0.3 | −0.36 |
| Serum 3 | 6.50b | 6.49 | 99.8 ± 0.2 | −0.15 |
| Serum 4 | 15.6b | 15.88 | 101.8 ± 0.9 | 1.79 |
ZPD mg/L urine.
ZPD μg/mL serum.
Average of five experiments.